Advera Health Analytics provides a range of products and services that enable better decision making and drive enhanced business performance through the use of evidence based data, analytics, and insights.


Evidence of a drug’s safety and efficacy are hard to find and always changing. You need to gather data quickly, conduct comprehensive analyses and make standardized comparisons to inform recommendations and decisions. Evidex software, powered by Advera Health’s clinical and real world data assets and analytics enable better decisions that lead to improved outcomes and lower costs.

Evidence Collection Made Easy:

  • Clinical evidence in Evidex is annotated data from curated clinical trial results that allow users to analyze the comparative effectiveness and safety and link those results to real world evidence, enabling better drug decisions that lead to improved outcomes and lower costs.
  • A drug’s safety profile is incomplete until it becomes widely used on the market. Evidex provides the highest quality, standardized and sourced real world evidence on drug side effects to track the evolving safety profile.
  • Quick searches and an intuitive UI empower use at both research and point-of-care settings. No data scientists or informatics team required!

Powerful Analytics Lead to Powerful Insight:

  • Evidex’s powerful attribute filters allow trial results to be segmented for customized pooled analyses and into quick monograph and publication friendly table creation
  • Linking clinical evidence with real world data enables powerful and insightful comparisons only found in Evidex
  • RxSignal® predictive algorithm forecasts future FDA action, uncovering serious side effects that were not seen in preapproval trials
  • Calculate the economic impact of drug side effects using RxCost® and communicate that risk with a FICO-like risk scorecard, RxScore®.

Head to Head Comparisons:

  • Quickly compare drugs by indication, class or mechanism of action
  • Identify differences in efficacy, safety, outcomes and costs that were previously unknown
  • Designed to fit into comparative effectiveness frameworks

Used To Lower Costs & Improve Outcomes By:

  • Pharmacy & Therapeutics (P&T) Committees
  • ADR Call Centers
  • Point-of-care clinical Pharmacy
  • Drug Utilization
  • Product Liability Insurers
  • Pharmaceutical Market Access, Medical Affairs, and HEOR


Advera Health's Advisory Services provides customized data, analytics, and insight to support market access and commercialization strategies at leading pharmaceutical companies.

Tell Your Drug's Evidence Story

Advera Health Advisory Services help Market Access groups tell their drug’s “evidence story” through data and insight that provide a complete understanding of the true comparative nature of drugs. Advera Health Advisory Services enables pharmaceutical companies to:

  • Help payers make decisions with the data they demand: providing head-to-head comparative research that P&T Committees require.
  • Demonstrate superior efficacy, safety, and economic profiles using annotated clinical trial results data and real world evidence.
  • Highlight market dynamics that make a drug’s market entrance successful.


  • Advise: Advisory services on how annotated clinical trial results data and real world data can be paired, and used separately, to answer client questions.
  • Hypothesize: Data gathering, summary and hypothesis testing and confirmation—our iterative process pinpoints the right data for the right situation.
  • Publish: Determining project scope -- including drug treatment regimens, classes, indications, adverse event terms and calculation methodologies, data is finalized and writing process begins through journal publication.

Data Licensing

Advera Health Analytics is the premier information source for drug evidence, providing the only scientifically validated and peer reviewed standardized data architecture and straight forward APIs to power leading software applications. We provide data for applications across multiple platforms that deliver drug evidence and data to multiple enterprise markets.

Drug Evidence Reviews & Special Reports

Drug Evidence Reviews and other Special Reports from Advera Health Analytics provide market leading comparative research that utilizes Advera Health Analytics' proprietary data and analytics. Each report provides an evidence review for newly launched (and soon-to-be launched) drugs vs. current market standard, deep dives into labeling changes and FDA safety communications and warnings, as well as evidence driven insight into other key drug issues.